论文部分内容阅读
肿瘤浸润淋巴细胞（TIL）的抗瘤活性是淋巴因子激活的杀伤细胞（LAK）的50～100倍。为了探讨喉癌患者TIL细胞治疗前后的免疫功能状况，笔者对23例输注自身TIL细胞的喉癌患者进行回输前后的外周血T淋巴细胞亚群检测与比较，现报告如下。1对象和方法1．1研究对象23例喉癌患者均经
The antitumor activity of tumor infiltrating lymphocytes (TIL) is 50 to 100 times that of lymphokine-activated killer cells (LAK). In order to explore the immune function of TIL cells before and after treatment in patients with laryngeal cancer, the author of 23 cases of transfusion of TIL cells in patients with laryngeal cancer before and after transfusion peripheral blood T lymphocyte subsets detection and comparison are as follows. 1 objects and methods 1.1 study of 23 cases of laryngeal cancer patients were